Skip to main content
Erschienen in: Urolithiasis 1/2023

01.12.2023 | Review

Conflicts of interest and the risk of bias are inevitable in urolithiasis research

verfasst von: Allen L. Rodgers

Erschienen in: Urolithiasis | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

This review examines data from stone conferences and research journals to assess whether justifiable concerns exist about possible bias in urolithiasis research and if so, how they can be minimized. Conflict of interest (COI) policies of two major urological congresses and three symposia dedicated to stone research were reviewed. Disclosure slides were viewed in webcasts and were evaluated for robustness and speaker compliance with respect to policy. Additionally, disclosure and COI policies of ten Science Citation Index (SCI)-approved journals were assessed and compared with actual declarations in published papers on urolithiasis. It was observed that disclosure and conflict declarations are frequently conflated in congresses and journals. Differences between the two ideologies appear to be ignored or unappreciated. Disclosures in the major urological meetings revealed a high percentage of financial relationships with industry. In dedicated stone conferences, more than two-thirds of speakers failed to display a declaration slide. Both scenarios generate questions about objectivity. Disclosure and COI statements in journals varied widely in format, detail and content. It is concluded that there exists a misinformed and incorrect perception in urolithiasis research that disclosure of potential COIs somehow validates a study as being objective and unbiased. Current policies and practices at conferences and in published papers create a setting in which concerns of bias prevail. Changes, including the establishment of a universal policy, insistence of independent and explicit declarations of disclosures and conflicts, implementation of sanctions for transgression and the introduction of intensive scrutiny by reviewers are required to minimize doubts.
Literatur
1.
Zurück zum Zitat Schoenthaler M, Miernik A, Wilhelm K, Schlager D, Schoeb DS, Adams F, Dahm P, Hein S (2016) Level of evidence, sponsorship, conflict of interest policy and commercial impact of PubMed-listed clinical urolithiasis-related trials in 2014. BJU Int 117:787–792CrossRefPubMed Schoenthaler M, Miernik A, Wilhelm K, Schlager D, Schoeb DS, Adams F, Dahm P, Hein S (2016) Level of evidence, sponsorship, conflict of interest policy and commercial impact of PubMed-listed clinical urolithiasis-related trials in 2014. BJU Int 117:787–792CrossRefPubMed
2.
Zurück zum Zitat Dunn AG, Coiera E, Mandl KD, Bourgeois FT (2016) Conflict of interest disclosure in biomedical research: a review of current practices, biases, and the role of public registries in improving transparency. Res Integ Peer Rev 1:1–8CrossRef Dunn AG, Coiera E, Mandl KD, Bourgeois FT (2016) Conflict of interest disclosure in biomedical research: a review of current practices, biases, and the role of public registries in improving transparency. Res Integ Peer Rev 1:1–8CrossRef
3.
4.
Zurück zum Zitat Crawford W, Camm CF, Prachee I, Ginks M (2019) Quality of conflicts of interest declarations in a conference setting–are audiences given a chance to adequately assess bias? Heart 105:A96–A97 Crawford W, Camm CF, Prachee I, Ginks M (2019) Quality of conflicts of interest declarations in a conference setting–are audiences given a chance to adequately assess bias? Heart 105:A96–A97
5.
Zurück zum Zitat Le Roux A, Touma NJ (2022) The value of conflicts of interest disclosures in oral presentations at major urological conferences. Soc Int Urol J 3:276–279CrossRef Le Roux A, Touma NJ (2022) The value of conflicts of interest disclosures in oral presentations at major urological conferences. Soc Int Urol J 3:276–279CrossRef
6.
Zurück zum Zitat Laube N, Grabowy U, Busch (2004) Novel analyzer allows rapid determination of urinary calcium oxalate stone formation risk. In: Gohel M, Au D (eds) Kidney Stones: Inside & Out: Proc 10th Int Symp Urolithiasis, Hong Kong, China. Reprographic Unit, Hong Kong Polytechnic University, pp 269 Laube N, Grabowy U, Busch (2004) Novel analyzer allows rapid determination of urinary calcium oxalate stone formation risk. In: Gohel M, Au D (eds) Kidney Stones: Inside & Out: Proc 10th Int Symp Urolithiasis, Hong Kong, China. Reprographic Unit, Hong Kong Polytechnic University, pp 269
14.
Zurück zum Zitat Stamatelou K (2022) Primary hyperoxaluria Type 1: Diagnosis, clinical manifestations, complications and medical management in the era of novel therapeutic options. 14th Meeting of the International Urolithiasis Society in conjunction with the 5th Experts in Stone Disease Conference, June 10–11, Athens, Greece 2022. https://www.youtube.com/watch?v=pR-cYAfu9B0. Accessed 19 Sept 2022 Stamatelou K (2022) Primary hyperoxaluria Type 1: Diagnosis, clinical manifestations, complications and medical management in the era of novel therapeutic options. 14th Meeting of the International Urolithiasis Society in conjunction with the 5th Experts in Stone Disease Conference, June 10–11, Athens, Greece 2022. https://​www.​youtube.​com/​watch?​v=​pR-cYAfu9B0. Accessed 19 Sept 2022
15.
Zurück zum Zitat Staios D (2022) Management of kidney stones in patients with PH1 – the urologist’s perspective. 14th Meeting of the International Urolithiasis Society in conjunction with the 5th Experts in Stone Disease Conference, June 10–11, Athens, Greece 2022. https://www.youtube.com/watch?v=pR-cYAfu9B0. Accessed 19 Sept 2022 Staios D (2022) Management of kidney stones in patients with PH1 – the urologist’s perspective. 14th Meeting of the International Urolithiasis Society in conjunction with the 5th Experts in Stone Disease Conference, June 10–11, Athens, Greece 2022. https://​www.​youtube.​com/​watch?​v=​pR-cYAfu9B0. Accessed 19 Sept 2022
18.
Zurück zum Zitat Baselga J (2018) Failure to disclose conflict of interest in article published in JAMA on detection of cancer-related genes. JAMA 320:2380CrossRefPubMed Baselga J (2018) Failure to disclose conflict of interest in article published in JAMA on detection of cancer-related genes. JAMA 320:2380CrossRefPubMed
23.
Zurück zum Zitat Rodgers A (2022) Are there conflicts of interest in urolithiasis research? Yes! 14th Meeting of the International Urolithiasis Society in conjunction with the 5th Experts in Stone Disease Conference, June 10–11, Athens, Greece 2022. https://www.youtube.com/watch?v=9f1JP1YJICs. Accessed 23 Nov 2022 Rodgers A (2022) Are there conflicts of interest in urolithiasis research? Yes! 14th Meeting of the International Urolithiasis Society in conjunction with the 5th Experts in Stone Disease Conference, June 10–11, Athens, Greece 2022. https://​www.​youtube.​com/​watch?​v=​9f1JP1YJICs. Accessed 23 Nov 2022
24.
Zurück zum Zitat Trinchieri A (2022) Are there conflicts of interest in urolithiasis research? No! 14th Meeting of the International Urolithiasis Society in conjunction with the 5th Experts in Stone Disease Conference, June 10–11, Athens, Greece 2022. https://youtu.be/bN7vxQawDPs. Accessed 23 Nov 2022 Trinchieri A (2022) Are there conflicts of interest in urolithiasis research? No! 14th Meeting of the International Urolithiasis Society in conjunction with the 5th Experts in Stone Disease Conference, June 10–11, Athens, Greece 2022. https://​youtu.​be/​bN7vxQawDPs. Accessed 23 Nov 2022
Metadaten
Titel
Conflicts of interest and the risk of bias are inevitable in urolithiasis research
verfasst von
Allen L. Rodgers
Publikationsdatum
01.12.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Urolithiasis / Ausgabe 1/2023
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-022-01397-0

Weitere Artikel der Ausgabe 1/2023

Urolithiasis 1/2023 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.